Westlund et al., 1982 - Google Patents
Effect of EACA, PAMBA, AMCA and AMBOCA on fibrinolysis induced by streptokinase, urokinase and tissue activatorWestlund et al., 1982
- Document ID
- 2049786315662176729
- Author
- Westlund L
- Lundén R
- Wallén P
- Publication year
- Publication venue
- Pathophysiology of Haemostasis and Thrombosis
External Links
Snippet
A study is presented in which the inhibiting effects of EACA, PAMBA, AMCA and AMBOCA on fibrinolysis induced by three activators have been compared by a clot lysis method. The order of inhibitory potency was AMBOCA> AMCA> PAMBA> EACA. The activity ratios …
- 239000012190 activator 0 title abstract description 34
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nilsson et al. | Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. | |
Teger-Nilsson et al. | Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate | |
Ødegård et al. | Heparin cofactor activity measured with an amidolytic method | |
Collen | On the regulation and control of fibrinolysis | |
Marder et al. | High molecular weight derivatives of human fibrinogen produced by plasmin: II. Mechanism of their anticoagulant activity | |
Harpel | Studies on human plasma α2-macroglobulin-enzyme interactions: evidence for proteolytic modification of the subunit chain structure | |
Vaziri et al. | Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris | |
Glas-Greenwalt et al. | Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus | |
US5994140A (en) | Stable coagulation controls | |
Epstein et al. | Radioimmunoassays for protein C and factor X: Plasma antigen levels in abnormal hemostatic states | |
Kirchhof et al. | The determination of prothrombin using synthetic chromogenic substrates; choice of a suitable activator | |
Kluft et al. | alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder. | |
EP0094720B1 (en) | Process for assaying the activity of tissue plasminogen activator, and kit suitable for use in said process | |
Clark et al. | Effects of recombinant erythropoietin on murine megakaryocytic colony formation in vitro | |
Geratz et al. | The inhibition of urokinase by aromatic diamidines | |
Hedner et al. | Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity | |
Saksela et al. | Plasminogen activators, activation inhibitors and alpha2‐macroglobulin produced by cultured normal and malignant human cells | |
Nilsson et al. | Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women | |
Westlund et al. | Effect of EACA, PAMBA, AMCA and AMBOCA on fibrinolysis induced by streptokinase, urokinase and tissue activator | |
Fareed et al. | Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overview. | |
Muller et al. | Effect of a moderate fish intake on haemostatic parameters in healthy males | |
Robbins | The human plasma fibrinolytic system: regulation and control | |
Weinstein et al. | Species specificity of the fibrinolytic effects of activated protein C | |
Seya et al. | Generation of C3d, g and C3d by urokinase-treated plasma in association with fibrinolysis | |
EP0324027A4 (en) | Improved assays for t-plasminogen activator and plasminogen activator inhibitor |